Cargando…
Buprenorphine Maintenance for Opioid Dependence in Public Sector Healthcare: Benefits and Barriers
BACKGROUND: Since its U.S. FDA approval in 2002, buprenorphine has been available for maintenance treatment of opiate dependence in primary care physicians’ offices. Though buprenorphine was intended to facilitate access to treatment, disparities in utilization have emerged; while buprenorphine trea...
Autores principales: | Duncan, Laura G., Mendoza, Sonia, Hansen, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4830502/ https://www.ncbi.nlm.nih.gov/pubmed/27088135 http://dx.doi.org/10.17352/2455-3484.000008 |
Ejemplares similares
-
Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018) -
Adherence to Buprenorphine Maintenance Treatment in Opioid Dependence Syndrome: A Case Control Study
por: Bandawar, Mrunal, et al.
Publicado: (2015) -
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder
por: Greenwald, Mark K., et al.
Publicado: (2023) -
Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017) -
Does buprenorphine maintenance improve the quality of life of opioid users?
por: Dhawan, A., et al.
Publicado: (2013)